Statistics
Publications
9
Citations
1.4K
H-Index
9
Active since
1999
Affiliations
Kevin Yee is an author at Oregon Health & Science University specializing in oncology, medicine, and flt3 inhibitors.
Publications per year
1999–2009
9
9
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 857 citations · Full text
Medicine, Oncology, Pharmacology +11
SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase
Kevin Yee, A O’Farrell, Beverly D. Smolich et al. · Blood · 2002 · 164 citations
Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells
Kevin Yee, Marcus M. Schittenhelm, Anne-Marie O'Farrell et al. · Blood · 2004 · 120 citations · Full text
Medicine, Oncology, Pharmacology +10
Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970
Amie S. Corbin, Ian J. Griswold, Paul La Rosée et al. · Blood · 2004 · 69 citations · Full text
Medicine, Cancer Biology, Oncology +14
1–5 of 9